RINGO WILLIAM R

CIK 000123832516 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001238325

Recent Transactions

50 trades

Award
ASSEMBLY BIOSCIENCES, INC.$ASMB
Stock Option (right to buy)
2025-06-05+3,500→ 3,500 total
Award
Faeth Therapeutics, Inc.$SNSE
Stock Option (Right to Buy)
2025-05-21+19,000→ 19,000 total
Award
Faeth Therapeutics, Inc.$SNSE
Stock Option (Right to Buy)
2024-06-11+19,000→ 19,000 total
Award
ASSEMBLY BIOSCIENCES, INC.$ASMB
Stock Option (right to buy)
2024-05-29+2,750→ 2,750 total
Award
Faeth Therapeutics, Inc.$SNSE
Common Stock
2023-07-10+4,466→ 23,399 total
Award
Faeth Therapeutics, Inc.$SNSE
Stock Option (Right to Buy)
2023-07-10+14,550→ 14,550 total
Award
ASSEMBLY BIOSCIENCES, INC.$ASMB
Stock Option (right to buy)
2023-05-25+20,000→ 20,000 total
Award
ASSEMBLY BIOSCIENCES, INC.$ASMB
Stock Option (right to buy)
2022-05-25+20,000→ 20,000 total
Award
Faeth Therapeutics, Inc.$SNSE
Common Stock
2022-03-08+10,000→ 18,933 total
Award
Faeth Therapeutics, Inc.$SNSE
Stock Option (Right to Buy)
2022-03-08+29,100→ 29,100 total
Award
Faeth Therapeutics, Inc.$SNSE
Common Stock
2022-03-08+8,933→ 8,933 total
Award
ASSEMBLY BIOSCIENCES, INC.$ASMB
Stock Option (right to buy)
2021-05-20+15,000→ 15,000 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2021-04-16−12,500→ 0 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2021-04-16−15,000→ 0 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2021-04-16−27,769→ 0 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2021-04-16−52,408→ 0 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2021-04-16−40,868→ 0 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2021-04-16−37,998→ 0 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2021-04-16−10,000→ 0 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2021-04-16−46,939→ 0 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2021-04-16−16,600→ 0 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2021-04-16−10,000→ 0 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2021-04-16−49,552→ 0 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2021-04-16−34,451→ 0 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2021-04-16−50,367→ 0 total
Gift
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2021-04-05−10,000→ 0 total
Sale
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2020-11-11$22.50/sh−26,000→ 10,000 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2020-11-11$2.22/sh+52,959→ 62,959 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2020-11-11$2.80/sh+26,000→ 36,000 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2020-11-11−52,959→ 0 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2020-11-11−26,000→ 52,408 total
Sale
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2020-11-11$22.50/sh−52,959→ 10,000 total
Award
ASSEMBLY BIOSCIENCES, INC.$ASMB
Stock Option (right to buy)
2020-06-11+10,000→ 10,000 total
Award
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2020-05-19+27,769→ 27,769 total
Award
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2020-04-19+78,408→ 78,408 total
Award
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2020-03-19+52,959→ 52,959 total
Gift
ASSEMBLY BIOSCIENCES, INC.$ASMB
Common Stock
2020-02-28−2,000→ 17,465 total
Disposition to Issuer
Dermira, Inc.
Director Stock Option (right to buy)
2020-02-20−18,275→ 0 total
Disposition to Issuer
Dermira, Inc.
Director Stock Option (right to buy)
2020-02-20−8,620→ 0 total
Disposition to Issuer
Dermira, Inc.
Director Stock Option (right to buy)
2020-02-20−6,000→ 0 total
Disposition to Issuer
Dermira, Inc.
Director Stock Option (right to buy)
2020-02-20−6,000→ 0 total
Disposition to Issuer
Dermira, Inc.
Restricted Stock Unit
2020-02-20−3,000→ 0 total
Disposition to Issuer
Dermira, Inc.
Director Stock Option (right to buy)
2020-02-20−10,344→ 0 total
Disposition to Issuer
Dermira, Inc.
Director Stock Option (right to buy)
2020-02-20−6,000→ 0 total
Disposition to Issuer
Dermira, Inc.
Common Stock
2020-02-20$18.75/sh−6,000→ 0 total
Award
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2020-02-19+37,998→ 37,998 total
Award
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2020-01-20+40,868→ 40,868 total
Award
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2020-01-20+40,868→ 40,868 total
Award
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2019-12-19+49,552→ 49,552 total
Award
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2019-11-19+50,367→ 50,367 total

Companies

Recent Filings

Address

PFIZER INC. ATT: CORPORATE SECRETARY 235 EAST 42ND STREET

NEW YORK, NY, 10017

View on SEC.gov